House of Commons photo

Crucial Fact

  • His favourite word was research.

Last in Parliament May 2004, as Liberal MP for Madawaska—Restigouche (New Brunswick)

Won his last election, in 2000, with 52% of the vote.

Statements in the House

MedicAlert Month May 23rd, 2002

Mr. Speaker, I am pleased to remind the House that May is MedicAlert Month.

The Canadian MedicAlert Foundation is a national registered charity that protects Canadians with medical information needs. For more than 40 years, MedicAlert has provided medical information services through engraved bracelets that provide health care professionals with access to a member's medical file stored in a confidential data base.

This year, as part of its mandate to protect children, MedicAlert has set a goal to educate people about protecting the health and safety of children and youth.

It is estimated that one third of all young Canadians between the ages of 6 and 19 have medical problems that must be treated. As summer approaches, MedicAlert hopes to protect these children and help them participate safely in outdoor activities during the summer, while providing peace of mind to parents.

Join me in wishing the Canadian MedicAlert Foundation a successful MedicAlert Month.

Health Care Spending May 8th, 2002

Mr. Speaker, first of all, I thank the hon. member for giving me the opportunity to rise in the House today to speak to Motion M-484.

The motion calls on the government to recognize every patient's right to timely and accurate diagnosis, and to improved access to new medications and to enjoy the same quality of care wherever they live. It also calls on the federal government to consider restoring federal funding to 25% of healthcare spending, moving towards restoring the federal contribution to 50% of total healthcare spending.

This motion raises issues near and dear to the hearts of many Canadians. We all know that healthcare is one of the profoundly important issues we must deal with today as a country.

On that point, the work currently being done by Mr. Romanow, the chair of the Commission on the Future of Healthcare in Canada, will make an important contribution to the national dialogue on healthcare. The commission was struck barely over a year ago, on April 4, 2001.

It has now entered the consultation phase or the public dialogue phase of its work. Its final recommendations are due in November. Its work will allow us to reach a consensus on how to reform the Canadian health care system. We are looking forward to what Mr. Romanow will recommend to ensure the long-term viability of the health care system.

I will now get back to the motion before us today and which, as I just said, is dealing with important issues such as quality of care, access to new medication and health care funding mechanisms. I would like to deal with each one of these three issues and tell all those who are here today what is being done in those areas.

To start with, I will say that quality of care is a notion which has several dimensions. We could say that a quality health care system is one that gives priority to the patient. It is integrated, flexible and efficient, and quality is a concern throughout the health care chain, from promotion to prevention and treatment.

The federal government keeps on working with the provinces, the territories, health care professionals and volunteer organizations to make sure that Canadians, wherever they live, have access in a timely fashion to the health care they need.

Let me give a few examples of the efforts made by the federal government to ensure quality health care.

We are working with our provincial and territorial partners and other interested parties to find the best solutions to deal with the issue of labour shortage in health care. For instance, in September 2001, the federal government announced a $3.95 million contribution over three years to a study on the physician workforce.

This study is being conducted in consultation with Human Resources Development Canada, Health Canada, the Federal-Provincial-Territorial Advisory Committee on Health Human Resources and representatives from the medical community. It is aimed at gathering evidence that will be used to develop a human resource strategy to improve the quality of care given Canadians and their access.

The report of the Commission on the Future of Health Care in Canada indicates that we need to reinforce our commitment to quality health care. Urging Canadians to take part in a study on health care delivery issues might be a great way to improve the flexibility of the health care system so that it can better meet the needs of patients.

Through the Canada Health Infostructure Partnerships Program, the Government of Canada recently announced an investment of up to $1 million in the Yukon Telehealth Network. This innovative project will deliver telehealth services and programs such as tele-mental health, tele-learning and X-ray support to six remote northern communities.It is believed that telehealth will significantly improve access to high quality health care.

Second, we know how important it is for the people of Canada to be able to rely on good diagnostic services and to have access to new, safe and efficient medication.

Although health care delivery, including hospital services and medical procedures, usually comes under provincial and territorial jurisdiction, the federal government still has an important role to play. It is funding medicare for almost one million Canadians in certain groups.

When the first ministers met in 2000, one of the priorities mentioned in the action plan for the renewal of our health care system was to guarantee all Canadians access to new medication that would be better suited to their health condition and more cost-efficient. Since that meeting, Health Canada, in concert with its provincial and territorial partners, has developed strategies to implement this priority.

For instance, federal, provincial and territorial health ministers have recently agreed to set up a single medication review process for all drug plans provided by both government orders. This will be great for Canadians, because it will ensure that all drugs go through a standardized and thorough review process.

Although the government does not support the motion before us today, it continues to work on strategies to improve access to new, appropriate and best value drugs, while ensuring the funding necessary for these strategies.

Finally, the motion before us today asks the government to commit to a specific contribution to health care funding. On this side of the House, we had numerous occasions in the last few years to debate this issue with members opposite, and I am pleased to do so again today.

The Canadian government provides funds to the provinces and the territories through the Canada health and social transfer.

The CHST is a block funding mechanism that applies to health care, post-secondary education, social welfare and social services. The provinces and the territories get to distribute the funds according to their priorities, but must abide by the principles of the Canada health act.

The Government of Canada is aware that the health care system needs stable and predictable funding. In September 2000, acknowledging the need to increase health care funding, the federal government decided to allocate, over five years, $21.1 billion of new money to the Canada health and social Transfer, including $2.2 billion for early childhood development.

Furthermore, the Canadian government has committed to invest $2.3 billion in three targeted areas, according to priorities which had been agree upon, namely frontline health care, biomedical equipment and information technology.

For the current fiscal year, namely 2002-2003, the total transfers from the federal government to the provinces and territories will reach an all time high of $19.l billion.

Together with the tax transfer component, CHST entitlements for 2002-2003 will reach $35.7 billion, or $6.3 billion more than in 1994-1995.

BY 2005-2006, the cash transfer of the CHST will have reached $21 billion, for an impressive total of $40 billion if we include fiscal transfers.

Moreover, wishing to improve predictability of funding, the federal government will determine by 2003-2004 the cash transfers for the years 2006-2007 and 2007-2008.

Moreover, the federal government is also making cash transfers as part of the equalization program, which allows provinces to provide their population with reasonably comparable levels of public care services, at reasonably comparable taxation levels. In 2002-2003, equalization payments should reach $10.2 billion.

The federal, provincial and territorial governments recognize that it takes more than money to improve access to quality health care.

The government I represent, in co-operation with its provincial and territorial partners and other stakeholders, is clearly taking active measures to meet the needs in terms of quality health care and access to new medication, and it is investing significantly in health care.

National Nursing Week May 7th, 2002

Mr. Speaker, every May, during National Nursing Week, we highlight and celebrate the contribution made by nurses throughout the year.

Registered nurses have a long tradition of caring for families as well as the knowledge and skills required to make a difference in the health care sector.

This year the theme of National Nursing Week is “Nurses Always There For You: Caring for Families”.

Every family is structured differently and has different roles. In all settings, there is a close relationship of trust between nursing professionals and individual family members, as well as with the family as a whole.

These relationships allow nurses to act as strong advocates in determining the best public policies for family health.

We have a responsibility to work with all citizens to promote health, prevent illness and provide health care treatments and rehabilitation. I encourage everyone to be inspired by professional pride and to participate actively in National Nursing Week.

Research and Development April 12th, 2002

Mr. Speaker, the fact remains that, again just recently, guidelines were introduced by the Canadian Institutes of Health Research. Our colleagues were not happy because they claimed it was not a step in the right direction. I am very sorry to see this.

Once again, the bill will be introduced and we hope that everyone will co-operate to make it law as soon as possible.

Research and Development April 12th, 2002

Mr. Speaker, we were obviously aware that this was coming. Science is moving ahead very quickly. That is why the Standing Committee on Health, of which my colleague is a member, worked very hard to table a report in the House.

The minister promised to introduce a bill before May 10. This will be done. We are going to proceed, but we must do so in a reasonable and comprehensive manner, and not just take a patchwork approach.

Contraventions Act and Controlled Drugs and Substances Act (marijuana) April 11th, 2002

Madam Speaker, we were both involved on this file and I realize there were other members in the House who were really involved in this. I would especially mention the member for Fredericton who approached me on a few occasions to talk about the file. It was a great result and it is good for Canadians.

Contraventions Act and Controlled Drugs and Substances Act (marijuana) April 11th, 2002

Madam Speaker, first I want to thank the hon. member for New Brunswick Southwest. There is no question that on this specific issue we have the same view. There is no question in my mind that this is a great example of what we can accomplish when we take the time to share information in a positive way and look at the objective we are reaching for. Even if we have different views at least we can co-operate. This is the way I was in my previous life when I worked as a physician in my own community. I welcome this type of approach here.

I believe that we on this side of the House have a role to play and the other side of the House has a role to play. It is a great demonstration of what we were able to accomplish in establishing priorities. There is no question about it. I was also aware of the importance and urgency of the situation for people from New Brunswick and people from the rest of Canada.

We were able, through this generous approach, to talk to each other, to focus on the objectives and to realize what was important to do. Through this we were able to have the Pest Management Regulatory Agency approve two new products. One is called ACQ and the other is called CBA. Through this the industry will be able to provide the new products on the market and at the same time slowly eliminate the other one, CCA. The producer has agreed that it will eliminate this in domestic products by 2003. It will remain available in industrial products.

This is great news and I want to thank the member again for his generous remarks to the minister. I hope that in the future we will be able to continue to work with this approach.

Health March 22nd, 2002

Mr. Speaker, earlier this week, the Minister of Health gave a response in this House indicating that steps have already been taken to improve the method of reporting adverse drug reactions and particularly to ensure that more would be done than just reporting them. Health workers need to have access to information in order to apply that information to their clinical practice, and this will really respond to the needs raised by the hon. member across the way.

Softwood Lumber March 22nd, 2002

Mr. Speaker, I thank the hon. member for his question. In spite of his aggressive tone, he was kind enough to inform me that he would ask this question. This allowed me to get the necessary information.

The Pest Management Regulatory Agency also obtained information from the American agency EPA to speed up the certification process of the chemical preservative CDA. I am sure that we will have a positive reply for the hon. member in the near future.

Health March 22nd, 2002

Mr. Speaker, I was very happy that this bill was introduced yesterday. People have been looking forward to this bill for many years and I think that it was very well received by all of the members of the House.

A closer look at the bill shows that many things have been changed to ensure that products put on the market are safe for people.

Furthermore, if they believe there is a health risk, the public or concerned associations will be able to request a review, in addition to the automatic review to be done every 15 years.